<DOC>
	<DOCNO>NCT00398996</DOCNO>
	<brief_summary>This randomize , open-label study compare three exist treatment strategy ART initiation HIV/TB co-infected patient : Group 1 : early initiation ART TB treatment , Group 2 : initiation ART upon completion intensive phase TB treatment , Group 3 : initiation ART upon completion continuation phase TB treatment Approximately 700 men woman â‰¥ 18 year age document HIV infection smear-positive pulmonary TB patient enrol . Eligible TB/HIV co-infected patient offer antiretroviral therapy ( ART ) , start one three time point list CAPRISA AIDS treatment programme include extensive counsel adherence support . The study participant follow 18 month assess primary study endpoint optimal time start antiretroviral therapy ( ART ) patient tuberculosis ( TB ) treatment compare clinical status ( CD4+ cell count , viral load , opportunistic infection .</brief_summary>
	<brief_title>A Study Compare Three Existing Starting Points Anti-Retroviral Therapy ( ART ) Initiation HIV/Tuberculosis ( TB ) Co-infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>HIV infect patient coinfected TB Receiving one standard antiTB therapy regimens All patient must agree use contraception since efavirenz . Entry treatment programme base clinical assessment patient clinically eligible maintain treatment regimen , entry may defer preclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>antiretroviral therapy</keyword>
	<keyword>HIV</keyword>
	<keyword>Opportunistic infection</keyword>
	<keyword>CD4</keyword>
	<keyword>Viral load</keyword>
	<keyword>TB/HIV co infection</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>